Colorado-based Gene-Editing Company gets Series C Financing
/
Inscripta Completes $20M Expansion of Series C Financing, Increasing Total Round to $105.5M
BOULDER, Colo.--(BUSINESS WIRE)--Inscripta, a leading gene editing technology company, today announced that it has increased its previously announced Series C financing with an additional $20 million from existing investors. The new funding adds to the $85.5 million financing Inscripta announced in 2018, bringing the total raised for the round to $105.5 million.
